Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine

BIOLOGICAL2 trials

Sponsors

Hospital Moinhos de Vento

Conditions

COVID-19Covid19

Unknown Phase

A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil

CompletedNCT05052307

Hospital Moinhos de VentoCovid19

Start: 2021-11-03End: 2023-07-20Updated: 2023-11-07

A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil

CompletedNCT05403307

Hospital Moinhos de VentoCOVID-19

Start: 2022-06-08End: 2023-07-17Updated: 2023-11-07

Related Papers

Real-world effectiveness of original BNT162b2 mRNA COVID-19 against symptomatic Omicron infection among children 5-11 years of age in Brazil: A prospective test-negative design study.

2024-07-26

BNT162b2 mRNA COVID-19 against symptomatic Omicron infection following a mass vaccination campaign in southern Brazil: A prospective test-negative design study

Vaccine2023-07-266 citations

BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan

PLoS ONE2022-10-203 citations